Senior medical device and healthcare services executive with a unique blend of sales, marketing, and financial skills. Strong experience in the process of product development through product launch with quantifiable sales results.

Zelegent Inc. is a medical technology company that is focused on reducing the severity of snoring, a common cause of both short-term and long-term health issues.Zelegent developed the Elevo® Snoring Intervention Set, which allows physicians to perform Elevoplasty® a minimally-invasive, physician’s office-based procedure, to treat patients with mild to moderate snoring who are not interested in wearing an oral appliance at night and who do not wish to undergo invasive, often hospital based, surgery.The S.I.LE.N.C.E. Clinical Study that was submitted to the FDA to achieve FDA Clearance** demonstrated that 3 out of 4 patients saw a reduction in snoring at 30 days post-procedure, and experienced significant and prolonged improvement of sleep quality and daytime alertness.– Approximately 45% of people snore at least sometimes and 25% of people snore regularly at volumes high enough to disturb sleeping partners.As for the snorer, the immediate negative effects include– excessive daytime sleepiness– increased agitation– decreased productivity– difficulty concentratingEven more concerning is the long-term negative impact that snoring has on an individual’s health by increasing the risk of– Obstructive Sleep Apnea (OSA)– Heart attack– High blood pressure– Carotid Artery thickening and atherosclerosis caused by snoring- associated vibration– Stroke, often caused by carotid artery thickening– Atrial fibrillation– Type 2 diabetesWhen one considers the numerous negative effects resulting from snoring and the current treatment options, Zelegent was driven to provide an alternative for those patients seeking relief from snoring who are not interested in wearing an oral appliance at night and do not wish to undergo invasive, often hospital based, surgery.

Start-up focused on developing a portfolio of respiratory protective masks with highly effective active and virucidal filtration.

Addinex Technologies, Inc. (www.AddinexTech.com) has developed a patented pharmaceutical dispensing system to alleviate the current opioid abuse epidemic.

BrainScope is a medical neuro-technology company that is pioneering the assessment of traumatic brain injury, including concussion.

Atrial Fibrillation DIvision

(acquired by Odyssey/Gentiva)

(Acquired by Hill-Rom)

Cardiac Rhythm Management DIvision